Olatec Industries LLC   Report issue

For profit Phase 2 Phase 3
Founded: New York NY United States (2003)

Organization Overview

First Clinical Trial
2012
NCT01636141
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Olatec Therapeutics LLC